I agree that this site is using cookies. You can find further informations here.
X
Bories, Pierre
330  results:
Search for persons X
?
1

Phthalate contamination in marine mammals off the Norwegian..:

Andvik, Clare ; Bories, Pierre ; Harju, Mikael...
Marine Pollution Bulletin.  199 (2024)  - p. 115936 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Dermatological toxicities induced by T-cell-redirecting G p..:

Lery, Marion ; Perrot, Aurore ; Ortiz-Brugués, Ariadna...
Journal of the American Academy of Dermatology.  90 (2024)  2 - p. 376-377 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Brexucabtagene autoleucel in relapsed or refractory mantle ..:

Herbaux, Charles ; Bret, Caroline ; Bachy, Emmanuel...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

P-306 Final results of a Phase 1b study of subcutaneous isa..:

Quach, Hang ; Parmar, Gurdeep ; Ocio, Enrique...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S206-S207 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUD..:

Garciaz, Sylvain ; Bories, Pierre ; Lopez Almeida, Leonor...
HemaSphere.  7 (2023)  S3 - p. e45170e9 , 2023
Link: https://doi.org/10.1097/..
 
?
6

Efficacy and safety of isatuximab plus bortezomib, lenalido..:

Ocio, Enrique M. ; Perrot, Aurore ; Bories, Pierre...
Leukemia.  37 (2023)  7 - p. 1521-1529 , 2023
Link: https://doi.org/10.1038/..
 
?
7

Nonrelapse mortality after CAR T-cell therapy for large B-c..:

Lemoine, Jean ; Bachy, Emmanuel ; Cartron, Guillaume...
Blood Advances.  7 (2023)  21 - p. 6589-6598 , 2023
Link: https://doi.org/10.1182/..
 
?
8

Efficacy and safety of crizotinib in ALK-positive systemic ..:

Brugières, Laurence ; Cozic, Nathalie ; Houot, Roch...
European Journal of Cancer.  191 (2023)  - p. 112984 , 2023
Link: https://doi.org/10.1016/..
 
?
9

The impact of physician's characteristics on decision-makin..:

Chabrillac, Emilien ; Lamy, Sébastien ; Grosclaude, Pascale...
Oral Oncology.  129 (2022)  - p. 105895 , 2022
Link: https://doi.org/10.1016/..
 
?
10

TheCADM1tumor suppressor gene is a major candidate gene in ..:

Lafage-Pochitaloff, Marina ; Gerby, Bastien ; Baccini, Véronique...
Blood Advances.  6 (2022)  2 - p. 386-398 , 2022
Link: https://doi.org/10.1182/..
 
?
11

Outcomes of patients with aggressive B-cell lymphoma after ..:

Di Blasi, Roberta ; Le Gouill, Steven ; Bachy, Emmanuel...
Blood.  140 (2022)  24 - p. 2584-2593 , 2022
Link: https://doi.org/10.1182/..
 
?
12

A real-world comparison of tisagenlecleucel and axicabtagen..:

Bachy, Emmanuel ; Le Gouill, Steven ; Di Blasi, Roberta...
Nature Medicine.  28 (2022)  10 - p. 2145-2154 , 2022
Link: https://doi.org/10.1038/..
 
?
13

Corrigendum to P-207: A multi-center, phase 1b study to ass..:

Moreau, Philippe ; Parmar, Gurdeep ; Prince, Miles...
Clinical Lymphoma Myeloma and Leukemia.  , 2022
Link: https://doi.org/10.1016/..
 
?
14

Poster: MM-071 Subcutaneous (SC) Isatuximab (Isa) Administr..:

Quach, Hang ; Parmar, Gurdeep ; Ocio, Enrique M....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S179 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Corrigendum to "OAB-005: Update of safety and efficacy of I..:

Ocio, Enrique ; Perrot, Aurore ; Bories, Pierre...
Clinical Lymphoma Myeloma and Leukemia.  , 2022
Link: https://doi.org/10.1016/..
 
1-15